688163 fundamentals
An in-depth look to SHANGHAI SERUM BIO-TECHNOLOGY operating, investing, and financing activities
688163 free cash flow for Q1 24 is -26.84 M CNY. For 2023, 688163 free cash flow was 21.86 M CNY and operating cash flow was 50.53 M CNY.
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: CNY
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
TTM